ARTICLE | Clinical News
Laquinimod: Phase IIa started
February 27, 2012 8:00 AM UTC
Active Biotech disclosed in its 4Q11 earnings that in November Teva completed enrollment of about 180 patients in a double-blind, placebo-controlled, dose-escalation Phase IIa trial evaluating 0.5, 1,...